nach oben

Pharmaceutical Medicine

Erschienen in:

31.05.2023 | Meeting Report

75th Annual Meeting of the American Academy of Neurology (AAN 2023)

verfasst von: Sue Pochon

Erschienen in: Pharmaceutical Medicine | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Excerpt

The 75th Annual Meeting of the American Academy of Neurology (AAN) was held in Boston (MA, USA) in April 2023. The meeting was attended by over 13,000 people and offered 6 days of first-class educational and scientific sessions. There were over 2600 abstracts and 2000 posters presented during the course of the meeting and made available through the virtual conference platform. …

Myers K, Berrahmoune S, Pekeles H, et al. Deoxycytidine/deoxythymidine combination therapy safety and efficacy in treatment of POLG-related disorders: results after 6 months of treatment. 2023 Annual Meeting of the American Academy of Neurology (AAN). 22-28 April; Boston, MA, USA. https://www.aan.com/MSA/Public/Events/AbstractDetails/55220. Accessed 11 May 2023.

Khella SL, Marques Jr W, Dasgupta NR, et al. Eplontersen in hereditary ATTR-polyneuropathy: week 66 final analysis of the phase 3 NEURO-TTRansform study. 2023 Annual Meeting of the American Academy of Neurology (AAN). 22-28 April; Boston, MA, USA. https://www.aan.com/MSA/Public/Events/AbstractDetails/55222 Accessed 11 May 2023.

McDonald CM, Wu S, Gulati S, et al. Safety and efficacy of ataluren in nmDMD patients from study 041, a phase 3, randomized, double-blind, placebo-controlled trial (PL5.001). Neurology. 2023;100(17 Supplement 2):2374. https://doi.org/10.1212/WNL.000000000020250.CrossRef

Barnett M, Beadnall H, Alexander Klistorner A, et al. VISIONARY-MS top-line results: a phase 2, randomized, double-blind, parallel group, placebo-controlled study to assess the safety and efficacy of CNM-Au8, a catalytically active gold nanocrystal suspension in relapsing multiple sclerosis (PL5.005). Neurology. 2023;100(17 Supplement 2):4273. https://doi.org/10.1212/WNL.0000000000203858.CrossRef

van Dyck CH, Swanson CJ, Aisen P, et al. Trial of lecanemab in early Alzheimer’s disease. N Engl J Med. 2023;388:9–21. https://doi.org/10.1056/NEJMoa2212948.CrossRefPubMed

Tassorelli C, Pozo-Rosich P, Nagy K, et al. Atogepant for the preventive treatment of migraine among participants with episodic migraine with prior treatment failure: results from the ELEVATE trial. 2023 Annual Meeting of the American Academy of Neurology (AAN). 22-28 April; Boston, MA, USA. https://www.aan.com/MSA/Public/Events/AbstractDetails/55231. Accessed 11 May 2023.

Lebrun Frenay C, Siva A, Sormani, MP, et al. Teriflunomide (Aubagio) Extends the time to multiple sclerosis in radiologically isolated syndrome: the TERIS study. 2023 Annual Meeting of the American Academy of Neurology (AAN). 22–28 April; Boston, MA, USA. https://www.aan.com/MSA/Public/Events/AbstractDetails/55234. Accessed 11 May 2023.

Titel: 75th Annual Meeting of the American Academy of Neurology (AAN 2023)
verfasst von: Sue Pochon
Publikationsdatum: 31.05.2023
Verlag: Springer International Publishing
Erschienen in: Pharmaceutical Medicine / Ausgabe 4/2023
Print ISSN: 1178-2595
Elektronische ISSN: 1179-1993
DOI: https://doi.org/10.1007/s40290-023-00481-z

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

75th Annual Meeting of the American Academy of Neurology (AAN 2023)

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2023

Embedding Patient-Centricity by Collaborating with Patients to Transform the Rare Disease Ecosystem

The Central Role of Ethics in Medical Affairs Practice

Interpersonal Values of Patients Participating in Phase II–III Clinical Trials: Implications for Clinical Trial Representativeness

Tackling Counterfeit Drugs: The Challenges and Possibilities

Meaningful Within-Patient Change on the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ): Analysis of Phase III Clinical Trial Data of Daridorexant

Major Pharmaceutical Conferences and Courses: October to November 2023